NCT04770454View on ClinicalTrials.gov

Evaluate the Quality of Life and Treatment of Anxiety Symptoms of Buspirone in Patients With Depression Disorders(BASIS)

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

March 30, 2023

Study Completion Date

March 30, 2023

Conditions
Depressive Disorder, MajorAnxiety Disorders
Trial Locations (1)

03127

the Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT04770454 - Evaluate the Quality of Life and Treatment of Anxiety Symptoms of Buspirone in Patients With Depression Disorders(BASIS) | Biotech Hunter | Biotech Hunter